lobbying_activities: 2818178

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2818178	99dc5c25-7c08-4d8f-b51f-33ec5137e2e1	Q2	ZERO PROSTATE CANCER	28388	ZERO PROSTATE CANCER	2022	second_quarter	INS	HR 1176 - the PSA Screening for HIM Act - to increase access to prostate cancer screening HR 4385/S3080 - The Cancer Drug Parity Act - to increase payment for orally-delivered cancer treatments	HOUSE OF REPRESENTATIVES,SENATE		110000	0	0	2022-07-13T13:45:14-04:00